Search for: "ACTAVIS"
Results 601 - 620
of 1,012
Sorted by Relevance
|
Sort by Date
27 Nov 2019, 7:38 am
Sara MoranThe Supreme Court held that the Court of Appeal was entitled to treat the judge’s failure to appreciate the logical consequence of a particular finding as an error of principle which allowed an appellate court to carry out its own evaluation. [read post]
14 Dec 2018, 7:55 pm
Sara MoranThe Court of Appeal overturned the Patent Court’s first instance decision concerning the validity of one of ICOS’s patents (licensed to Eli Lilly) covering a 1 to 5mg dosage form of tadalafil (Cialis®) for oral administration up to a maximum of 5mg per day for the treatment of sexual dysfunction. [read post]
19 Dec 2019, 9:41 am
In his reference, the Judge trotted through the English court's and CJEU's case law Article 3(a) - Takeda, Farmitalia, Daiichi, Yeda, Medeva (and its progeny), Actavis v Sanofi, Eli Lilly v HGS, Actavis v Boehringer, - and found that it was clear that something more was required, but what that "something" was was not clear. [read post]
18 Oct 2017, 7:32 am
Adair reinforced the “very low” threshold for plausibility adopted by the English courts (see Carr J in Actavis v Lilly [2015] EWHC 3294) – this was different to the “fair expectation of success” in the inventive step inquiry. [read post]
8 May 2009, 11:16 am
Actavis Totowa LLC, 2009 WL 1082026 (N.D. [read post]
24 Mar 2014, 10:39 am
Actavis, Inc., Androderm Endo Pharmaceuticals, Fortesta Testosterone Gel Auxilium Pharmaceuticals, Inc., Testim Testosterone Gel BioSante/Teva, Bio-T-Gel [read post]
24 Jan 2014, 9:58 am
The complete agenda is as follows: Day 1: USA, Canada, and Mexico Analysing the scope and implications of Inter Partes Review (IPR) in the United States after one year Evaluating reverse payment settlement cases and decisions after Actavis Determining patent eligibility for a US patent and ascertaining ways to use attorney fees/cost shifting for the benefit of pharmaceutical companies Formulating the best litigation strategies in the US to optimise costs for pharma and biopharma… [read post]
21 Sep 2014, 8:00 pm
Akamai Will Impact ANDA Litigation Involving Method of Treatment Patents FTC Keynote: Reverse Payment Settlements and Other Antitrust Concerns Impacting Paragraph IV Litigation in the Wake of Actavis The Ever Shifting Boundaries of the Safe Harbor: Determining the Scope of 271(e)(1) Protections Relative to Paragraph IV Litigation After Classen and Momenta New Exclusivity Challenges for Brand Names and Generics: Exploring Their Implications for Paragraph IV Challenges The Uncertain… [read post]
31 Jan 2008, 12:10 am
Actavis Group hfU.S. [read post]
20 Jun 2014, 7:58 pm
" Here is the complete agenda: Unearthing Changes at the Office of Generic Drugs and Understanding Their Impact on the Future Growth and Evolution of the Generic Drug Industry Deciphering GDUFA and Its Impact on ANDA Approvals, Profit Margins, and Performance Metrics Demystifying the FDA's Rulemaking Authority: Exploring How FDA's Proposed Labeling Rule and Other Proposed Rules and Guidances Will Affect the Dynamics of the Generic Pharmaceutical Industry The Changing Paradigm of the… [read post]
9 Oct 2009, 9:11 am
Actavis Elizabeth LLC, Anchen Pharmaceuticals Inc. and Anchen Incorporated (patent infringement) 10/6: Pfizer Inc., Pfizer Pharmaceuticals LLC, Pfizer Ireland Pharmaceuticals, Pfizer Limited and CP Pharmaceuticals International CV v. [read post]
24 Feb 2012, 12:59 pm
• In 2011, Texas won a $170 million jury verdict against Actavis for falsely reporting their wholesale drug prices to the Medicaid program. [read post]
19 Jan 2010, 12:00 am
To round out the picture, in a slightly more expected vein (read completely expected) was the Eli Lilly V Actavis (Strattera case). [read post]
11 Jun 2014, 1:01 pm
Actavis. [read post]
17 Feb 2010, 6:09 am
Readers with good memories may recall the decision of Mr Justice Warren (Patents Court, England and Wales) in Actavis v Novartis [2009] EWHC 41 (Ch) (noted briefly by the IPKat here) concerning the validity of Novartis's European patent EP0948320 which claimed a sustained release formulation for fluvastatin, a drug intended to prevent heart attacks caused by high cholesterol. [read post]
7 Apr 2014, 8:53 pm
Here is the complete agenda: On the 30th Anniversary of the Drug Price Competition and Patent Term Restoration Act: Understanding Hatch-Waxman's Transformative Impact on the Pharmaceutical Industry Assessing Pharmaceutical Patent Sustainability and Vulnerability: Strategies and Considerations for Brand Names and Generics in Anticipating, Identifying and Determining Which Patents Will be Ripe for Challenges of Invalidity and Non-Infringement Use of IPR and Other PTO Proceedings in a Paragraph… [read post]
21 Sep 2014, 8:00 pm
Akamai Will Impact ANDA Litigation Involving Method of Treatment Patents FTC Keynote: Reverse Payment Settlements and Other Antitrust Concerns Impacting Paragraph IV Litigation in the Wake of Actavis The Ever Shifting Boundaries of the Safe Harbor: Determining the Scope of 271(e)(1) Protections Relative to Paragraph IV Litigation After Classen and Momenta New Exclusivity Challenges for Brand Names and Generics: Exploring Their Implications for Paragraph IV Challenges The Uncertain… [read post]
4 Jan 2010, 8:19 pm
Fentanyl pain patches are also sold by Mylan, Watson and Actavis. [read post]
19 Sep 2008, 6:48 am
Most of this went over the IPKat's head, but there appears to be one main lesson from this, which is that if you are considering relying on the exemption it's best to get some very heavy duty advice first unless you like living dangerously.The highlight of the evening, however, was Tom Hinchliffe who talked about the recent case of Actavis v Merck (see the IPKat's commentary here). [read post]
30 Nov 2012, 8:19 am
(Omega AG) (Omega Ltd.) [2012] EWHC 3440 (Ch) (30 November 2012) Cometson & Anor v Merthyr Tydfil County Borough Council & Anor [2012] EWHC 3446 (Ch) (30 November 2012) High Court (Patents Court) Actavis Group HF v Eli Lilly & Company [2012] EWHC 3316 (Pat) (27 November 2012) High Court (Queen’s Bench Division) Hussain v King Edward VII Hospital [2012] EWHC 3441 (QB) (30 November 2012) O’Dwyer v ITV Plc [2012] EWHC 3321 (QB) (30 November 2012) Harries v Stevenson… [read post]
